Dr Reddys US Sales

Dr Reddy’s Lab Shares Rise 4% On Pact With Alvotech For Biosimilar Development

Dr Reddy’s Lab Shares Rise 4% On Pact With Alvotech For Biosimilar Development

BY Outlook Business Desk

Dr Reddy’s Profit More Than Doubles To Rs 1,188 Crore In Q1 On Higher Other Income

Dr Reddy’s Profit More Than Doubles To Rs 1,188 Crore In Q1 On Higher Other Income